ProPhase Labs, Inc. Public Market Comparables
Find the most relevant public market comparables for ProPhase Labs, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
ProPhase Labs, Inc. is a next-generation biotech, genomics, and consumer products company focused on creating healthier lives through bold action and insightful innovation. They are revolutionizing healthcare with industry-leading whole genome sequencing solutions and developing diagnostics and therapeutics in the fight against cancer, including a potentially life-saving esophageal cancer test. They also develop, manufacture, and commercialize health and wellness solutions.
Business Model
ProPhase Labs operates through multiple segments including diagnostic services (offering whole genome sequencing and cancer diagnostics), and consumer products (developing and marketing over-the-counter health products and dietary supplements). The company is also exploring strategic options, including a potential sale of its subsidiary, Nebula Genomics.
Target Customers
Healthcare providers, consumers (direct-to-consumer marketing for dietary supplements), health plans, third-party payers, and government organizations (for diagnostic services).
Specific Focus
Whole genome sequencing, cancer diagnostics (especially esophageal cancer), and over-the-counter health and wellness products.
Location
Garden City, New York
CEO
Ted Karkus
Industry
Life sciences
Sub Sector
Biotechnology, Genomics, Diagnostics
3yr Revenue Growth
206%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to ProPhase Labs, Inc. in the Healthcare sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for ProPhase Labs, Inc.? Our platform provides detailed analysis of ProPhase Labs, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full ProPhase Labs, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full ProPhase Labs, Inc. Compset
As a leading player in the Life sciences industry within the Healthcare sector, ProPhase Labs, Inc. operates in the specialized Biotechnology, Genomics, Diagnostics sub-sector. Understanding how ProPhase Labs, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology, Genomics, Diagnostics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Tango Therapeutics, Inc.
Biotechnology • Life sciences
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. They leverage the genetic principle of synthetic lethality to discover and develop therapies targeting critical cancer targets.
Sutro Biopharma Inc.
Biotechnology • Life sciences
Sutro Biopharma, Inc. is a clinical-stage oncology company focused on discovering and developing precisely designed cancer therapeutics using its proprietary cell-free protein synthesis platform, XpressCF+. The company develops next-generation protein therapeutics for cancer and autoimmune disorders, focusing on antibody-drug conjugates (ADCs), cytokine-based immuno-oncology therapies, and bispecific antibodies.
Aytu BioPharma, Inc.
Pharmaceuticals • Life sciences
Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on commercializing novel therapeutics. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), and has a commercial portfolio of prescription therapeutics and consumer health products.
Get Your Custom Comparable Analysis
Need a more detailed analysis of ProPhase Labs, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free